Logo image of CORT

CORCEPT THERAPEUTICS INC (CORT) Stock Overview

NASDAQ:CORT - US2183521028 - Common Stock

71.34 USD
-0.04 (-0.06%)
Last: 9/3/2025, 4:20:51 PM
70.6 USD
-0.74 (-1.04%)
After Hours: 9/3/2025, 4:20:51 PM

CORT Key Statistics, Chart & Performance

Key Statistics
52 Week High117.33
52 Week Low34.25
Market Cap7.52B
Shares105.37M
Float93.13M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)1.13
PE63.13
Fwd PE28.99
Earnings (Next)10-28 2025-10-28/amc
IPO04-15 2004-04-15
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


CORT short term performance overview.The bars show the price performance of CORT in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 10 15 20 25

CORT long term performance overview.The bars show the price performance of CORT in the last 1, 2 and 3 years. 1 year 2 years 3 years 50 100 150

The current stock price of CORT is 71.34 USD. In the past month the price decreased by -0.54%. In the past year, price increased by 107.62%.

CORCEPT THERAPEUTICS INC / CORT Daily stock chart

CORT Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 45.69 698.33B
JNJ JOHNSON & JOHNSON 17.8 428.68B
AZN ASTRAZENECA PLC-SPONS ADR 18.49 254.58B
NVO NOVO-NORDISK A/S-SPONS ADR 14.55 252.12B
NVS NOVARTIS AG-SPONSORED ADR 14.49 248.23B
MRK MERCK & CO. INC. 10.93 210.26B
PFE PFIZER INC 7.31 140.94B
SNY SANOFI-ADR 11.29 121.68B
BMY BRISTOL-MYERS SQUIBB CO 7.06 96.68B
GSK GSK PLC-SPON ADR 8.77 79.29B
ZTS ZOETIS INC 24.51 67.55B
TAK TAKEDA PHARMACEUTIC-SP ADR 52.24 47.85B

About CORT

Company Profile

CORT logo image Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company is headquartered in Redwood City, California and currently employs 500 full-time employees. The company went IPO on 2004-04-15. The firm is engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol. The firm operates through the discovery, development and commercialization of the pharmaceutical products segment. The firm has marketed Korlym (mifepristone) in the United States for the treatment of patients suffering from Cushings syndrome. The Company’s portfolio of selective cortisol modulators consists of four series totaling approximately 1,000 compounds. Its portfolio of selective cortisol modulators consists of relacorilant, dazucorilant and miricorilant. Korlyms active ingredient, mifepristone, reduces the binding of excess cortisol to the GR, it can modulate the effects of abnormal levels and release patterns of cortisol without compromising cortisols healthy functions and rhythms.

Company Info

CORCEPT THERAPEUTICS INC

101 Redwood Shores Parkway

Redwood City CALIFORNIA 94025 US

CEO: Joseph K. Belanoff

Employees: 500

CORT Company Website

CORT Investor Relations

Phone: 16506888803

CORCEPT THERAPEUTICS INC / CORT FAQ

What is the stock price of CORCEPT THERAPEUTICS INC today?

The current stock price of CORT is 71.34 USD. The price decreased by -0.06% in the last trading session.


What is the ticker symbol for CORCEPT THERAPEUTICS INC stock?

The exchange symbol of CORCEPT THERAPEUTICS INC is CORT and it is listed on the Nasdaq exchange.


On which exchange is CORT stock listed?

CORT stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for CORCEPT THERAPEUTICS INC stock?

10 analysts have analysed CORT and the average price target is 137.19 USD. This implies a price increase of 92.3% is expected in the next year compared to the current price of 71.34. Check the CORCEPT THERAPEUTICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is CORCEPT THERAPEUTICS INC worth?

CORCEPT THERAPEUTICS INC (CORT) has a market capitalization of 7.52B USD. This makes CORT a Mid Cap stock.


How many employees does CORCEPT THERAPEUTICS INC have?

CORCEPT THERAPEUTICS INC (CORT) currently has 500 employees.


What are the support and resistance levels for CORCEPT THERAPEUTICS INC (CORT) stock?

CORCEPT THERAPEUTICS INC (CORT) has a support level at 70.97 and a resistance level at 72.16. Check the full technical report for a detailed analysis of CORT support and resistance levels.


Is CORCEPT THERAPEUTICS INC (CORT) expected to grow?

The Revenue of CORCEPT THERAPEUTICS INC (CORT) is expected to grow by 24.8% in the next year. Check the estimates tab for more information on the CORT EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy CORCEPT THERAPEUTICS INC (CORT) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does CORCEPT THERAPEUTICS INC (CORT) stock pay dividends?

CORT does not pay a dividend.


When does CORCEPT THERAPEUTICS INC (CORT) report earnings?

CORCEPT THERAPEUTICS INC (CORT) will report earnings on 2025-10-28, after the market close.


What is the Price/Earnings (PE) ratio of CORCEPT THERAPEUTICS INC (CORT)?

The PE ratio for CORCEPT THERAPEUTICS INC (CORT) is 63.13. This is based on the reported non-GAAP earnings per share of 1.13 and the current share price of 71.34 USD. Check the full fundamental report for a full analysis of the valuation metrics for CORT.


What is the Short Interest ratio of CORCEPT THERAPEUTICS INC (CORT) stock?

The outstanding short interest for CORCEPT THERAPEUTICS INC (CORT) is 11.37% of its float. Check the ownership tab for more information on the CORT short interest.


CORT Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to CORT. When comparing the yearly performance of all stocks, CORT is one of the better performing stocks in the market, outperforming 92.45% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

CORT Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to CORT. CORT scores excellent points on both the profitability and health parts. This is a solid base for a good stock.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CORT Financial Highlights

Over the last trailing twelve months CORT reported a non-GAAP Earnings per Share(EPS) of 1.13. The EPS decreased by 0% compared to the year before.


Industry RankSector Rank
PM (TTM) 18.66%
ROA 16.67%
ROE 21.02%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-9.38%
Sales Q2Q%18.7%
EPS 1Y (TTM)0%
Revenue 1Y (TTM)25.71%

CORT Forecast & Estimates

10 analysts have analysed CORT and the average price target is 137.19 USD. This implies a price increase of 92.3% is expected in the next year compared to the current price of 71.34.

For the next year, analysts expect an EPS growth of -1.91% and a revenue growth 24.8% for CORT


Analysts
Analysts82
Price Target137.19 (92.3%)
EPS Next Y-1.91%
Revenue Next Year24.8%

CORT Ownership

Ownership
Inst Owners80.63%
Ins Owners6.55%
Short Float %11.37%
Short Ratio9.78